GSK (GSK) News Today $33.46 +0.02 (+0.04%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?January 20 at 12:27 PM | msn.comFLC Capital Advisors Makes New $279,000 Investment in GSK plc (NYSE:GSK)FLC Capital Advisors bought a new position in GSK plc (NYSE:GSK - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 8,238 shares of the pharmaceutical company's stock, valued at approximately $279,000. Other hedge funds and other iJanuary 20 at 8:11 AM | marketbeat.comGlaxoSmithKline (GSK) Receives a Hold from JefferiesJanuary 20 at 7:26 AM | markets.businessinsider.comM.E. Allison & CO. Inc. Takes $314,000 Position in GSK plc (NYSE:GSK)M.E. Allison & CO. Inc. acquired a new position in GSK plc (NYSE:GSK - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 9,286 shares of the pharmaceutical company's stock, valued at approximatelyJanuary 20 at 7:15 AM | marketbeat.comGSK: European Commission Expands Jemperli Plus Chemotherapy Approval - Quick FactsJanuary 20 at 2:25 AM | markets.businessinsider.comSpero Therapeutics: Undervalued Based On Just Tebipenem And GSK DealJanuary 19 at 9:06 AM | seekingalpha.comJ2 Capital Management Inc Acquires Shares of 17,613 GSK plc (NYSE:GSK)J2 Capital Management Inc bought a new position in GSK plc (NYSE:GSK - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 17,613 shares of the pharmaceutical company's stock, valued at approximately $596,000. Several other inJanuary 19 at 7:22 AM | marketbeat.comPark Avenue Securities LLC Sells 7,722 Shares of GSK plc (NYSE:GSK)Park Avenue Securities LLC decreased its stake in shares of GSK plc (NYSE:GSK - Free Report) by 12.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 52,519 shares of the pharmaceutical company's stock after selling 7,722 shares during the quaJanuary 19 at 3:26 AM | marketbeat.comGSK Executives Acquire Shares Through Dividend ReinvestmentJanuary 16, 2025 | tipranks.comStock Traders Buy Large Volume of GSK Put Options (NYSE:GSK)January 15, 2025 | americanbankingnews.comHallucinations in AI: How GSK is addressing a critical problem in drug developmentJanuary 14, 2025 | venturebeat.comGSK Target of Unusually High Options Trading (NYSE:GSK)GSK plc (NYSE:GSK - Get Free Report) was the target of some unusual options trading activity on Tuesday. Traders bought 10,769 put options on the company. This represents an increase of approximately 79% compared to the average volume of 6,021 put options.January 14, 2025 | marketbeat.comGSK CEO Optimistic About Dealmaking, Trump AdministrationJanuary 14, 2025 | msn.comGSK plc (GSK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)January 14, 2025 | seekingalpha.comKeystone Financial Planning Inc. Has $7.71 Million Position in GSK plc (NYSE:GSK)Keystone Financial Planning Inc. increased its position in shares of GSK plc (NYSE:GSK - Free Report) by 3,660.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 227,913 shares of the pharmaceutical company's stock afterJanuary 13, 2025 | marketbeat.comJTC Employer Solutions Trustee Ltd Sells 202,398 Shares of GSK plc (NYSE:GSK)JTC Employer Solutions Trustee Ltd lessened its position in GSK plc (NYSE:GSK - Free Report) by 1.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,278,564 shares of the pharmaceutical company's stock after selling 202,398 shares dJanuary 13, 2025 | marketbeat.comThomasville National Bank Has $16.62 Million Holdings in GSK plc (NYSE:GSK)Thomasville National Bank lifted its position in shares of GSK plc (NYSE:GSK - Free Report) by 3.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 491,441 shares of the pharmaceutical company's stock after purchasingJanuary 13, 2025 | marketbeat.comDrugmaker GSK Buys US Firm Focused On Gastro CancerJanuary 13, 2025 | barrons.comGSK (NYSE:GSK) Reaches New 52-Week Low - Here's WhyGSK (NYSE:GSK) Reaches New 12-Month Low - What's Next?January 13, 2025 | marketbeat.comGSK Executives Acquire Shares Following Dividend ReinvestmentJanuary 13, 2025 | tipranks.comGSK (NYSE:GSK) Upgraded to "Strong-Buy" at StockNews.comStockNews.com raised GSK from a "buy" rating to a "strong-buy" rating in a report on Monday.January 13, 2025 | marketbeat.comGSK to buy US biotech firm IDRx for up to $1.15 billionJanuary 13, 2025 | reuters.comGSK Enters Agreement to Acquire IDRx, Inc.January 13, 2025 | businesswire.comJPMorgan Chase & Co. Reduces Stock Position in GSK plc (NYSE:GSK)JPMorgan Chase & Co. trimmed its position in shares of GSK plc (NYSE:GSK - Free Report) by 70.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 370,815 shares of the pharmaceutical company's stock after selling 900,251 shaJanuary 11, 2025 | marketbeat.comKepler Capital Keeps Their Hold Rating on GlaxoSmithKline (GSK)January 11, 2025 | markets.businessinsider.comGSK remains steady Friday, still outperforms marketJanuary 10, 2025 | marketwatch.comGSK's Shingrix New Prefilled Syringe Presentation Accepted For Review By FDAJanuary 10, 2025 | markets.businessinsider.comPharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO's Expanded DealJanuary 10, 2025 | msn.comOuro, backed by GSK, joins hunt to bring bispecifics to autoimmune diseaseJanuary 10, 2025 | yahoo.comGSK plc (NYSE:GSK) Receives $43.25 Average Target Price from BrokeragesJanuary 10, 2025 | americanbankingnews.comCWA Asset Management Group LLC Lowers Stock Position in GSK plc (NYSE:GSK)CWA Asset Management Group LLC reduced its position in GSK plc (NYSE:GSK - Free Report) by 65.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,210 shares of the pharmaceutical company's stock after selling 30,397 shares duJanuary 9, 2025 | marketbeat.comGSK in advanced talks to purchase U.S. biotech IDRx, FT reportsJanuary 8, 2025 | markets.businessinsider.comDouglas Lane & Associates LLC Sells 544,979 Shares of GSK plc (NYSE:GSK)Douglas Lane & Associates LLC reduced its stake in GSK plc (NYSE:GSK - Free Report) by 25.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,628,504 shares of the pharmaceutical company's stock after selling 544,979 shaJanuary 8, 2025 | marketbeat.comInvesTrust Acquires Shares of 101,298 GSK plc (NYSE:GSK)InvesTrust bought a new position in GSK plc (NYSE:GSK - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 101,298 shares of the pharmaceutical company's stock, valued at approximately $3,422,000. Other institutionalJanuary 8, 2025 | marketbeat.comFDA requires GSK and Pfizer vaccines to carry rare side effect warningsJanuary 7, 2025 | investing.comGSK and Pfizer's RSV vaccines to carry warnings of neurological disorder riskJanuary 7, 2025 | reuters.comGSK’s GSK’227 receives FDA BTD for treating adults with relapsed osteosarcomaJanuary 7, 2025 | markets.businessinsider.comGSK hails FDA breakthrough therapy designation for bone cancer drugJanuary 7, 2025 | lse.co.ukFDA Grants Breakthrough Therapy Designation To GSK's GSK5764227 For Bone CancerJanuary 7, 2025 | markets.businessinsider.comBernstein Remains a Buy on GlaxoSmithKline (GSK)January 7, 2025 | markets.businessinsider.comGSK plc (NYSE:GSK) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of GSK plc (NYSE:GSK - Get Free Report) have received a consensus rating of "Moderate Buy" from the ten research firms that are covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a hold rating and three have issued a strong buy rating on the company.January 7, 2025 | marketbeat.comBard Financial Services Inc. Purchases 21,950 Shares of GSK plc (NYSE:GSK)Bard Financial Services Inc. lifted its holdings in GSK plc (NYSE:GSK - Free Report) by 38.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 79,095 shares of the pharmaceutical company's stock aftJanuary 6, 2025 | marketbeat.comGSK (NYSE:GSK) Downgraded to Buy Rating by StockNews.comStockNews.com cut shares of GSK from a "strong-buy" rating to a "buy" rating in a research note on Sunday.January 5, 2025 | marketbeat.comGSK Updates Shareholders on Voting Rights and Capital StructureJanuary 2, 2025 | tipranks.comCan GSK plc (LON:GSK) Maintain Its Strong Returns?December 30, 2024 | uk.finance.yahoo.comGSK’s combo therapy trial for advanced ovarian cancer meets primary endpointDecember 23, 2024 | msn.comVisiting Your Local Pharmacy and Risk for Shingles and Vaccination options with GSK and Giant EagleDecember 23, 2024 | yahoo.comGSK Directors Show Confidence with Share PurchasesDecember 23, 2024 | tipranks.comFranklin Resources Inc. Raises Position in GSK plc (NYSE:GSK)Franklin Resources Inc. raised its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 8.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 235,348 shares of the pharmaceutical company'December 22, 2024 | marketbeat.comGSK reports mixed findings from ovarian cancer phase III studyDecember 20, 2024 | lse.co.uk Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.670.44▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼1512▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Novartis News Today Sanofi News Today Takeda Pharmaceutical News Today argenx News Today BioNTech News Today Teva Pharmaceutical Industries News Today BeiGene News Today Summit Therapeutics News Today Genmab A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GSK Stock Alerts